Artiva Biotherapeutics, Inc. Quarterly Accrued Liabilities, Current in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Artiva Biotherapeutics, Inc. quarterly Accrued Liabilities, Current history and growth rate from Q4 2023 to Q3 2024.
  • Artiva Biotherapeutics, Inc. Accrued Liabilities, Current for the quarter ending September 30, 2024 was $8.34M.
Accrued Liabilities, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $8.34M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $6.21M Jun 30, 2024 10-Q 2024-08-29
Q4 2023 $8.02M Dec 31, 2023 10-Q 2024-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.